Patients who undergo hematopoietic stem‐cell transplantation (HSCT) are more susceptible
to developing severe forms of COVID‐19 with an increased risk of mortality. The aim of this …

The global outbreak of COVID-19 possesses serious challenges and adverse impacts for
patients with progression of chronic liver disease and has become a major threat to public …

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) is a serious hazard for
hemodialysis (HD) patients and kidney transplant (KTX) recipients as they suffer from an …

Background: In liver transplant (LT) recipients, immunosuppressive therapy may potentially
increase the risk of severe COVID-19 and may increase the mortality in patients. However …

Background & Aims Liver transplant recipients (LTRs) demonstrate a reduced response to
COVID-19 mRNA vaccination; however, a detailed understanding of the interplay between …

The coronavirus disease 2019 pandemic has significantly impacted liver tran splantation
worldwide, leading to major effects on the transplant process, including the pretransplant …

The low response to vaccines is a well-known problem in cirrhosis. We evaluated the safety
and immunogenicity of booster doses in patients with chronic liver disease (CLD) …

Several cases of fatal pneumonia during November 2019 were linked initially to severe
acute respiratory syndrome coronavirus 2, which the World Health Organization later …

The Coronavirus Disease 2019 (COVID-19) pandemic has substantially impacted solid
organ transplantation, including temporary inactivation of waitlist candidates with COVID-19 …

Background and aims COVID-19 vaccination has proved to be effective to prevent
symptomatic infection and severe disease even in immunocompromised patients including …